Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

451 - 460 of 564 results found

Guillain-Barré Syndrome Following the BNT162b2 mRNA COVID-19 Vaccine

Date
Wednesday, May 17, 2023 - 4:00 AM
Description
CONCLUSION: Guillain-Barré syndrome after COVID-19 vaccination is responsive to treatment. The benefits of administering the vaccine outweigh the risks. Due to the negative impact of COVID-19, it is essential to recognize the development of

Galectin-3 as a Marker for Increased Thrombogenicity in COVID-19

Date
Saturday, May 13, 2023 - 4:00 AM
Description
Galectin-3 is a beta-galactoside-binding lectin involved in inflammation and lung fibrosis and postulated to enhance thrombosis. In COVID-19, it is considered to be a prognostic marker of severity. The aim of this study was to evaluate whether